• Introduced
    Jan 21, 2026
  • Passed House
    Feb 09, 2026
  • Passed Senate
  • Became Law
HB 1099
South Dakota House Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.
Last Action See all actions
Senate • Feb 26, 2026: Remove from Consent Calendar, S.J. 412
SECOND READING OF HOUSE BILLS AND JOINT RESOLUTIONS Senate
Mar 02, 2026 02:00pm
Senate

Summary

Comments on HB 1099

Tweets

Whip Lists

Sponsors
Votes
Actions
  • Feb 26, 2026 | Senate
    • Remove from Consent Calendar, S.J. 412
  • Feb 25, 2026 | Senate
    • Health and Human Services Scheduled for hearing, S.J. 1
    • Health and Human Services Do Pass, Passed YEAS: 6, NAYS: 0, S.J. 21
    • Health and Human Services Certified uncontested, placed on consent, S.J. 21
  • Feb 10, 2026 | Senate
    • First read in Senate and referred to Health and Human Services, S.J. 234
  • Feb 09, 2026 | House
    • Do Pass, Passed YEAS: 58, NAYS: 7, H.J. 265
  • Feb 05, 2026 | House
    • Health and Human Services Scheduled for hearing, H.J. 1
    • Health and Human Services Do Pass, Passed YEAS: 13, NAYS: 0, H.J. 13
  • Jan 21, 2026 | House
    • First read in House and referred to Health and Human Services, H.J. 104
Documents
Looks like we don't have any documents available at this moment.